首页 | 本学科首页   官方微博 | 高级检索  
     

100例乳腺癌雌激素和孕激素受体的测定和分析
引用本文:刘思齐 王盛乾. 100例乳腺癌雌激素和孕激素受体的测定和分析[J]. 癌症, 1992, 11(2): 123-126
作者姓名:刘思齐 王盛乾
作者单位:四川重庆市肿瘤研究所,四川重庆市肿瘤研究所,四川重庆市肿瘤研究所 重庆 630030,重庆 630030,重庆 630030
摘    要:对100例乳腺癌选用ER和PR抗血清,采用ABC法进行免疫组化染色,结果发现:ER和PR同时阳性者为40例(40%),ER和PR同时阴性者为26例(26%);所有病例随访3~4年,40例ER和PR同时阳性中有1例复发,占2.5%,26例ER和PR同时阴性中有12例复发,占46.2%,二者有显著差异性(P<0.01)。结果提示:乳腺癌ER和PR同时阳性病预后较阴性病例好,因此,同时测定乳腺癌ER和PR对临床制定乳腺癌的治疗方案和判定预后有重大价值和意义。

关 键 词:乳腺癌 雌激素受体 孕激素受体

THE ANALYSIS AND DETECTION OF ESTROGEN AND PRO-GESTERONE RECEPTORS IN 100 CASES OF BREAST CANCER
LIU Si-qi WANG Sheng-qian YANG Jia-xiang. THE ANALYSIS AND DETECTION OF ESTROGEN AND PRO-GESTERONE RECEPTORS IN 100 CASES OF BREAST CANCER[J]. Chinese journal of cancer, 1992, 11(2): 123-126
Authors:LIU Si-qi WANG Sheng-qian YANG Jia-xiang
Abstract:Breast cancer specimens from 100 patients were stained for the estrogen receptors (ER) and progestin receptors (PR) by the Avidin-Biotin Peroxidase-Complex (ABC) immunohistochemistry method. The results showed that both ER and PR were positive in 40 cases(40%), Both negative in 26 cases(26%). During 3 to 4 years follow-up period, one of 40 cases with ER and PR positive presented with recurrences (2.5%), whereas 12 of 26 cases with ER and PR negative group recured (46.2%). This differnce is significant (p<0.01). These results indicats that breast cancer patients with simultaneous ER and PR positive have a better prognosis than those negative patients. Therefore, the simultaneous measurement of ER and PR has the adrantages for taking clinical therapy and estimating prognosis of breast cancer.
Keywords:Breast Cancer Estrogen receptors Progestin receptors
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号